智通财经APP讯,明基医院(02581)发布公告,鉴于香港联合交易所有限公司证券上市规则附录C1所载企业管治守则第二部分守则条文第B.3.5条,并考虑本公司的实际情况后,于2026年3月9日,非执行董事王黎明博士及独立非执行董事王文聪先生已获委任为本公司提名委员会成员,自 2026年3月9日起生效。
智通财经APP讯,明基医院(02581)发布公告,鉴于香港联合交易所有限公司证券上市规则附录C1所载企业管治守则第二部分守则条文第B.3.5条,并考虑本公司的实际情况后,于2026年3月9日,非执行董事王黎明博士及独立非执行董事王文聪先生已获委任为本公司提名委员会成员,自 2026年3月9日起生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.